The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis

Cancer Cell

Volumn 11, Issue 4, 2007, Pages 349-360

  Carrasco, Daniel R ^a   Sukhdeo, Kumar ^a   Protopopova, Marina ^a,b   Sinha, Raktim ^a   Enos, Miriam ^a   Carrasco, Daniel E ^a   Zheng, Mei ^a   Mani, Mala ^a   Henderson, Joel ^a   Pinkus, Geraldine S ^a   Munshi, Nikhil ^a,b   Horner, James ^a   Ivanova, Elena V ^a,b   Protopopov, Alexei ^a,b   Anderson, Kenneth C ^a,b   Tonon, Giovanni ^a   DePinho, Ronald A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

CELLCYCLE

Indexed keywords

IMMUNOGLOBULIN; ISOPROTEIN; X BOX BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE LESION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMU GENE; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEPOSITION; LYMPHOID CELL; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MONOCLONAL IMMUNOGLOBULINEMIA; MOUSE; MULTIPLE MYELOMA; NONHUMAN; ONCOGENE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SPLICING; SUBENDOTHELIUM; TRANSGENE; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; XBP 1S GENE;

MUS MUSCULUS;

AGING; ANIMALS; B-LYMPHOCYTES; BONE DISEASES; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; DROMAIIDAE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOPLASMIC RETICULUM; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIPLE MYELOMA; NUCLEAR PROTEINS; PLASMA CELLS; RNA SPLICING; SKIN DISEASES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 34047136169     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.02.015     Document Type: Article

References (40)

1. Bergsagel P.L., and Kuehl W.M. Molecular pathogenesis and a consequent classification of multiple myeloma. J. Clin. Oncol. 23 (2005) 6333-6338
2. Calfon M., Zeng H., Urano F., Till J.H., Hubbard S.R., Harding H.P., Clark S.G., and Ron D. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415 (2002) 92-96
3. Calvano S.E., Xiao W., Richards D.R., Felciano R.M., Baker H.V., Cho R.J., Chen R.O., Brownstein B.H., Cobb J.P., Tschoeke S.K., et al. A network-based analysis of systemic inflammation in humans. Nature 437 (2005) 1032-1037
4. Carrasco D., Tonon G., Huang Y., Zhang Y., Sinha R., Feng B., Zhan F., Khatry D., Protopopova M., Protopopov A., et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 9 (2006) 313-325
5. Cheung W.C., Kim J.S., Linden M., Peng L., Van Ness B., Polakiewicz R.D., and Janz S. Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice. J. Clin. Invest. 113 (2004) 1763-1773
6. Davies F.E., Dring A.M., Li C., Rawstron A.C., Shammas M.A., O'Connor S.M., Fenton J.A., Hideshima T., Chauhan D., Tai I.T., et al. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood 102 (2003) 4504-4511
7. Dispenzieri A. POEMS Syndrome. Hematology Am. Soc. Hematol. Educ. Program (2005) 360-367
8. Fujimoto T., Onda M., Nagai H., Nagahata T., Ogawa K., and Emi M. Upregulation and overexpression of human X-box binding protein 1 (hXBP-1) gene in primary breast cancers. Breast Cancer 10 (2003) 301-306
9. Gagliardi M., Maynard S., Miyake T., Rodrigues N., Tjew S.L., Cabannes E., and Bedard P.A. Opposing roles of C/EBPbeta and AP-1 in the control of fibroblast proliferation and growth arrest-specific gene expression. J. Biol. Chem. 278 (2003) 43846-43854
10. Garrett I.R., Dallas S., Radl J., and Mundy G.R. A murine model of human myeloma bone disease. Bone 20 (1997) 515-520
11. Gass J.N., Gunn K.E., Sriburi R., and Brewer J.W. Stressed-out B cells? Plasma cell differentiation and the unfolded protein response. Trends Immunol. 25 (2004) 17-24
12. He B., Chadburn A., Jou E., Schattner E.J., Knowles D.M., and Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J. Immunol. 172 (2004) 3268-3279
13. Herrera G.A., Joseph L., Gu X., Hough A., and Barlogie B. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch. Pathol. Lab. Med. 128 (2004) 875-879
14. Iwakoshi N.N., Lee A.H., and Glimcher L.H. The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response. Immunol. Rev. 194 (2003) 29-38
15. Iwakoshi N.N., Lee A.H., Vallabhajosyula P., Otipoby K.L., Rajewsky K., and Glimcher L.H. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 4 (2003) 321-329
16. Kemp D.J., Harris A.W., Cory S., and Adams J.M. Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. Proc. Natl. Acad. Sci. USA 77 (1980) 2876-2880
17. Kuehl W.M., and Bergsagel P.L. Multiple myeloma: Evolving genetic events and host interactions. Nat. Rev. Cancer 2 (2002) 175-187
18. Kyle R.A., and Gertz M.A. Systemic amyloidosis. Crit. Rev. Oncol. Hematol. 10 (1990) 49-87
19. Le Gouill S., Podar K., Harousseau J.L., and Anderson K.C. Mcl-1 regulation and its role in multiple myeloma. Cell Cycle 3 (2004) 1259-1262
20. Lee K., Tirasophon W., Shen X., Michalak M., Prywes R., Okada T., Yoshida H., Mori K., and Kaufman R.J. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 16 (2002) 452-466
21. Lee A.H., Iwakoshi N.N., Anderson K.C., and Glimcher L.H. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc. Natl. Acad. Sci. USA 100 (2003) 9946-9951
22. Li X.-D., Lankinen H., Putkuri N., Vapalahti O., and Vaheri A. Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology 333 (2005) 180-189
23. Ma Y., and Hendershot L.M. The unfolding tale of the unfolded protein response. Cell 107 (2001) 827-830
24. McDonald J.P., Frank E.G., Plosky B.S., Rogozin I.B., Masutani C., Hanaoka F., Woodgate R., and Gearhart P.J. 129-derived strains of mice are deficient in DNA polymerase iota and have normal immunoglobulin hypermutation. J. Exp. Med. 198 (2003) 635-643
25. Mitsiades C.S., Mitsiades N., Munshi N.C., and Anderson K.C. Focus on multiple myeloma. Cancer Cell 6 (2004) 439-444
26. Munshi N.C., Hideshima T., Carrasco D., Shammas M., Auclair D., Davies F., Mitsiades N., Mitsiades C., Kim R.S., Li C., et al. Identification of genes modulated in multiple myeloma using genetically identical twin samples. Blood 103 (2004) 1799-1806
27. Novak A.J., Darce J.R., Arendt B.K., Harder B., Henderson K., Kindsvogel W., Gross J.A., Greipp P.R., and Jelinek D.F. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: A mechanism for growth and survival. Blood 103 (2004) 689-694
28. Park S.S., Kim J.S., Tessarollo L., Owens J.D., Peng L., Han S.S., Tae Chung S., Torrey T.A., Cheung W.C., Polakiewicz R.D., et al. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Cancer Res. 65 (2005) 1306-1315
29. Reimold A.M., Iwakoshi N.N., Manis J., Vallabhajosyula P., Szomolanyi-Tsuda E., Gravallese E.M., Friend D., Grusby M.J., Alt F., and Glimcher L.H. Plasma cell differentiation requires the transcription factor XBP-1. Nature 412 (2001) 300-307
30. Sebastian T., and Johnson P.F. Stop and go: Anti-proliferative and mitogenic functions of the transcription factor C/EBPbeta. Cell Cycle 5 (2006) 953-957
31. Shaffer A.L., Shapiro-Shelef M., Iwakoshi N.N., Lee A.H., Qian S.B., Zhao H., Yu X., Yang L., Tan B.K., Rosenwald A., et al. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21 (2004) 81-93
32. Shahidi H., Myers J.L., and Kvale P.A. Castleman's disease. Mayo Clin. Proc. 70 (1995) 969-977
33. Shen X., Ellis R.E., Lee K., Liu C.Y., Yang K., Solomon A., Yoshida H., Morimoto R., Kurnit D.M., Mori K., and Kaufman R.J. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell 107 (2001) 893-903
34. Sirohi B., and Powles R. Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. Eur. J. Cancer 42 (2006) 1671-1683
35. Spets H., Stromberg T., Georgii-Hemming P., Siljason J., Nilsson K., and Jernberg-Wiklund H. Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: Regulation during interleukin-6(IL-6)-induced growth and survival. Eur. J. Haematol. 69 (2002) 76-89
36. Takeshita F., Suzuki K., Sasaki S., Ishii N., Klinman D.M., and Ishii K.J. Transcriptional regulation of the human TLR9 gene. J. Immunol. 173 (2004) 2552-2561
37. Tonon G., Wong K.K., Maulik G., Brennan C., Feng B., Zhang Y., Khatry D.B., Protopopov A., You M.J., Aguirre A.J., Martin E.S., Yang Z., Ji H., Chin L., and DePinho R.A. High-resolution genomic profiles of human lung cancer. Proc. Natl. Acad. Sci. USA 102 (2005) 9625-9630
38. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98 (2001) 5116-5121
39. Wen X.Y., Stewart A.K., Sooknanan R.R., Henderson G., Hawley T.S., Reimold A.M., Glimcher L.H., Baumann H., Malek L.T., and Hawley R.G. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells. Int. J. Oncol. 15 (1999) 173-178
40. Zhan F., Hardin J., Kordsmeier B., Bumm K., Zheng M., Tian E., Sanderson R., Yang Y., Wilson C., Zangari M., et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99 (2002) 1745-1757